Loading stock data…
VREX
$11.61-0.04 (-0.34%)
Market ClosedLast close May 1
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Varex Imaging Corporation in the Healthcare sector is trading at $11.61. The stock is currently 20% below its 52-week high of $14.56, remaining 0.2% below its 200-day moving average. Technical signals show neutral RSI of 52 and bearish MACD signal, explaining why VREX maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$11.61
Potential Upside
5%
Whystock Fair Value$12.19
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus5 analysts
Buy
Mean target$18.40+58.5%
Range$16.00 – $22.00
Fundamentals
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray t...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$508.90M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
1.00
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.20%
Volume
Today's trading volume
278,565
Recent News
Wall Street Analysts Think VAREX IMAGING (VREX) Could Surge 63.19%: Read This Before Placing a Bet
The consensus price target hints at a 63.2% upside potential for VAREX IMAGING (VREX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Are Investors Undervaluing VAREX IMAGING (VREX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's Why
VAREX IMAGING (VREX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts See a 57.62% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 57.6% in VAREX IMAGING (VREX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
How The Varex Imaging (VREX) Story Is Shifting With New Risk And Earnings Assumptions
The recent $2 adjustment in Varex Imaging’s price target, with fair value held at $18.40, has prompted a closer look at how the stock’s risk and earnings story is being framed. Bullish and bearish analysts are reading the same move in different ways, ranging from better alignment with the company’s risk profile to questions about how much of the future narrative is built into the new target. As you read on, you will see how to track these shifting assumptions and what they might mean for your...